Searched for
JUPITER BIOSCIENCE
Corporate actions this week: IRFC, Gujarat Gas to go ex-dividend, Power Grid Corporation ex-bonus and moreThe ex-dividend date is when the price of the equity shares of a company gets adjusted for the dividend payout. It is one or two working da...- Jupiter Biosciences in talks to buy Swiss co; stock upJupiter Biosciences is in advanced discussion to buy privately-held Swiss pharma company SynphaBase for about $10 million to boost drug res...
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 mHyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
- Jupiter Bioscience in negotiation for Rs 75 cr contract; stock upShares of Jupiter Bioscience moved higher after the company announced that it is in negotiation with European multinational pharmaceutical ...
- Peptide is an emerging field in pharma: Venkat R Kalavakolanu, CMD, Jupiter BioscienceIn a chat with ET Now, Venkat R Kalavakolanu, CMD, Jupiter Bioscience, talks about the peptide business.
- Looking for targets of 115-120 in Jupiter Biosciences: Devang Visaria, devangvisaria.comDevang Visaria, Chief Strategist, devangvisaria.com, in a chat with ET Now talks about his stock ideas.
- Ranbaxy in talks to acquire Bangalore vaccine co for Rs 50-crRanbaxy Laboratories has started discussions to buy a privately-held Bangalore-based vaccine company, two persons familiar with the develop...
- Investor ire over share pledging hits Jupiter Bio, Assam Co, VideoconUpset over promoters pledging shares in their company, investors were selling Jupiter Bioscience, Assam Company and Videocon Industries in ...
- Fate of Ranbaxy-Jupiter deal hangs in balancePharma major Ranbaxy Laboratories has missed the deadline for conversion of equity warrants issued by Jupiter Bioscience.
- Global meltdown raises joint venture opportunities in biotechThe global meltdown may lead to more joint ventures and acquisitions among the foreign and domestic biotech companies in the current fiscal...
- Daiichi buys promoter stake in Ranbaxy at Rs 737 per shareJapanese drugmaker Daiichi Sankyo has bought entire 35 per cent promoters stake in Ranbaxy Laboratories at Rs 737 per share.
- Indian drug cos prepare a peptide mixAs blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
- Ranbaxy picks up 14.9% stake in JupiterRanbaxy Laboratories has acquired 14.9% stake in Hyderabad-based specialised compound maker Jupiter Bioscience for Rs 46 crore.
- Ranbaxy buys 15 pc stake in Jupiter BioRanbaxy acquired the stake in Jupiter Bioscience as part of its product portfolio expansion.
- Jupiter Bio to issue 32 lakh warrants to RanbaxyJupiter Bioscience, a manufacturer of specialised organic compounds, on Tuesday said it will issue up to 31.77 lakh equity share warrants t...
- Jupiter Bio ropes in Dubai FIs to fund expansionTwo Dubai-based financial institutions are set to invest $15 million in Hyderabad-based specialised organic compound manufacturer Jupiter B...
- Jupiter gets nod for stake sale to RanbaxyIn a filing to BSE, Jupiter Bioscience said its board of directors have ratified the term sheet.
- Ranbaxy, Jupiter Bioscience enter into marketing tie-upRanbaxy Laboratories is about to enter into a 10-year co-marketing agreement with Jupiter Bioscience to tap the $6-billion global peptide p...
- Ranbaxy to pick stake in Jupiter BioThe firm said it would seek the approval for the proposal from its Board of Directors on April 12.
- Ranbaxy to pick up stake in JupiterJupiter Bioscience on Thrusday said that it plans to allot preferential equity share warrants to Ranbaxy.
Load More- Jupiter Bioscience in negotiation for Rs 75 cr contract; stock up
